info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » healthcare

Healthcare

Cancer Registry Software Market By Deployment Model (On-Premise, Cloud-Based); By Type of Software (Standalone, Integrated); By Database Type (Hospital-Based, Population-Based, Specialty); By End User (Hospitals and Cancer Centers, Public Health Agencies, Pharmaceutical Companies and CROs, Academic and Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cancer Registry Software Market will post a steady CAGR of 9.4% , valued at around $1.25 billion in 2024 , expected to expand and reach nearly $2.... Read More

Published Date: NOV-2025 | No Of Pages:164 | $ 4485

Real-World Evidence (RWE) Solutions Market By Product Type (Software Solutions, Services); By Application (Drug Development & Market Authorization, Post-Market Surveillance, Regulatory Decision-Making); By End User (Pharmaceutical & Biotech Companies, Healthcare Providers, Regulatory Bodies, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction and Strategic Context

The Global Real-World Evidence (RWE) Solutions market is projected to witness robust growth between 2024 and 2030. Estimated at USD 3.5 billion in 2024, the market is anticipated to grow at a Read More

Published Date: NOV-2025 | No Of Pages:161 | $ 4485

Enzyme Immunoassay Market By Product Type (Reagents & Kits, Instruments & Analyzers); By Application (Infectious Disease Testing, Oncology, Endocrinology, Drug Testing & Toxicology, Autoimmune & Allergy Diagnostics); By End User (Hospitals & Diagnostic Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Point-of-Care & Home Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Enzyme Immunoassay Market is set to expand at a promising CAGR of 7.2% , growing from an estimated USD 3.1 billion in 2024 to nearly USD 5.0 billion by 2030Read More

Published Date: NOV-2025 | No Of Pages:161 | $ 4485

Long-Term Care Software Market By Product Type (Clinical Software, Non-Clinical Software); By Deployment Mode (Cloud-Based, On-Premises); By End User (Nursing Homes, Assisted Living Facilities, Home Health Agencies, Hospice Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Long-Term Care Software Market will witness a steady CAGR of 9.1% , valued at $5.9 billion in 2024 , and projected to exceed $9.8 billion by 2030 , accord... Read More

Published Date: NOV-2025 | No Of Pages:179 | $ 4485

Nucleic Acid Amplification Testing (NAAT) Market By Test Type (DNA Testing, RNA Testing); By Technology (PCR, Isothermal Amplification, CRISPR); By Application (Infectious Disease Diagnostics, Genetic & Oncology Testing, Blood Screening); By End User (Hospitals, Diagnostic Laboratories, Academic Institutes, Point-of-Care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Nucleic Acid Amplification Testing ( NAAT ) Market will witness a robust CAGR of 10.6 % , valued at USD 3.8 bill... Read More

Published Date: NOV-2025 | No Of Pages:167 | $ 4485

Ultrasound Image Analysis Software Market By Software Type (Standalone, Integrated); By Application (Cardiology, Obstetrics and Gynecology, Radiology/General Imaging, Vascular Applications); By End User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers and Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ultrasound Image Analysis Software Market will experience a healthy CAGR of 12.4% , valued at approximately USD 1.6 billion in 2024 . It’s projected to expand and re... Read More

Published Date: NOV-2025 | No Of Pages:153 | $ 4485

Capillary Electrophoresis Market By Product Type (Instruments, Consumables); By Application (Pharmaceutical & Biotechnology Analysis, Genomics & DNA Sequencing, Food & Environmental Testing, Academic & Research); By End User (Pharmaceutical & Biotech Companies, Academic & Research Institutes, Contract Research Organizations, Forensic & Environmental Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Capillary Electrophoresis Market will witness a robust CAGR of 6.8% , valued at around USD 875 million in 2024, expected to appreciate and reach nearly USD 1.3 bil... Read More

Published Date: NOV-2025 | No Of Pages:168 | $ 4485

Mental Health Screening Market By Screening Method (Traditional, Digital Tools); By Application (Clinical Settings, Workplace, Public Health Initiatives); By End User (Healthcare Providers, Workplace Wellness Programs, Government Organizations, Educational Institutions); By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Mental Health Screening Market is poised for significant growth, driven by rising awareness of mental health issues, technological advancements, and an increasingly supportive regulatory environment. In 2024, the... Read More

Published Date: NOV-2025 | No Of Pages:182 | $ 4485

Cardiology Electronic Health Records (EHR) Market By Product Type (Cloud-Based, On-Premise, Hybrid); By End-User (Hospitals, Cardiology Clinics, ASCs, Research Institutions); By Deployment Mode (Cloud, On-Premise, Hybrid); By Region (North America, Europe, Asia Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cardiology Electronic Health Records (EHR) Market will experience a notable expansion, projected to grow at a CAGR of 7.8% , valued at $3.5 billio... Read More

Published Date: NOV-2025 | No Of Pages:179 | $ 4485

Esoteric Testing Market By Test Type (Infectious Disease, Oncology, Genetic & Genomic, Endocrinology & Immunology); By Technology (RT-PCR, NGS, Flow Cytometry, Mass Spectrometry); By End User (Reference Labs, Hospitals, CROs, Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Esoteric Testing Market will grow at a promising CAGR of 9.2 % , estimated at $31.2 billion in 2024 and projected to reach nearly Read More

Published Date: NOV-2025 | No Of Pages:178 | $ 4485

AI in Cancer Diagnostics Market By Component (Software Tools, Hardware Systems, Services); By Cancer Type (Breast, Lung, Prostate, Colorectal, Others); By Application (Medical Imaging, Pathology, Genomics, Risk Stratification); By End User (Hospitals, Diagnostic Labs, Academic Institutions, Pharma & Biotech); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global AI i n Cancer Diagnostics Market will witness a robust CAGR of 26.4% , valued at $1.6 billion in 2024 , and is projected... Read More

Published Date: NOV-2025 | No Of Pages:172 | $ 4485

Non-Invasive Prenatal Testing (NIPT) Market Non Invasive Prenatal Testing Market By Test Type (Aneuploidy Screening, Microdeletion Panels, Sex Chromosome Testing); By Technology (Next-Generation Sequencing, Microarray, PCR-Based); By End User (Diagnostic Laboratories, Hospitals & Clinics, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Non-Invasive Prenatal Testing ( NIPT ) Market will grow at a strong CAGR of 11.4% , valued at USD 5.3 billion in 2024 and projected to hi... Read More

Published Date: NOV-2025 | No Of Pages:154 | $ 4485

Anatomic Pathology Market By Product Type (Instruments, Consumables, Services); By Application (Disease Diagnosis, Drug Development, Research); By End User (Hospitals & Surgical Centers, Diagnostic Labs, Academic Institutes, Biopharma & CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Anatomic Pathology market will witness a steady CAGR of 9.5 % , valued at $ 40.8 billion in 2024 , expe... Read More

Published Date: NOV-2025 | No Of Pages:153 | $ 4485

Oncology Information System Market By Product Type (Software, Services); By Application (Medical Oncology, Radiation Oncology, Surgical Oncology); By End User (Hospitals & Cancer Research Centers, Outpatient Oncology Clinics, Government Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Oncology Information System Market will witness a robust CAGR of 9.2 %, valued at $5.3 billion in 2024, expected to appr... Read More

Published Date: NOV-2025 | No Of Pages:183 | $ 4485

Acute Care Telemedicine Market By Service Type (Tele-ICU, Tele-Stroke, Tele-Emergency, Others); By Application (Neurology, Cardiology, Pulmonology, Trauma Care, Multi-Specialty Emergency); By End User (Hospitals & Health Systems, Standalone Emergency Centers, ASCs, Government and Military Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Acute Care Telemedicine Market will witness a robust CAGR of 17.8% valued at $5.6 billion in 2024 , expected to appreciate and reach $15.9 billion by 2030 Read More

Published Date: NOV-2025 | No Of Pages:169 | $ 4485

AI in Ophthalmology Market By Product Type (Diagnostic Platforms, Clinical Decision Support Software, Surgical Robotics & Workflow Automation); By Application (Retinal Disease Diagnosis, Glaucoma Management, Cataract Detection & Surgical Planning, Other Applications); By End User (Hospitals & Specialty Clinics, Standalone Ophthalmic Centers, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global AI In Ophthalmology Market will witness a robust CAGR of 24.1% , valued at $1.9 billion in 2024 , expected to appreciate and reach Read More

Published Date: NOV-2025 | No Of Pages:170 | $ 4485

Computer-Aided Detection Market By Modality (X-ray, CT, MRI, Ultrasound, Nuclear Medicine); By Application (Oncology, Cardiovascular, Neurology, Others); By End User (Hospitals, Diagnostic Imaging Centers, Academic & Research); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Computer-Aided Detection ( CAD ) Market will witness a strong CAGR of 11.2 % , valued at $1.27 billion in 2024 , an... Read More

Published Date: NOV-2025 | No Of Pages:177 | $ 4485

Personalized Cancer Vaccines Market By Vaccine Type (Neoantigen-Based, Dendritic Cell, RNA-Based); By Cancer Type (Melanoma, Lung Cancer, Glioblastoma, Colorectal Cancer, Others); By End User (Academic & Research Institutes, Hospitals & Cancer Centers, Biotechnology & Pharma Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Personalized Cancer Vaccines Market will witness a robust CAGR of 19.8% , valued at $3.2 billion in 2024 , expected to appreciate and reach $9.5 billion by 2030Read More

Published Date: NOV-2025 | No Of Pages:166 | $ 4485

Hemostasis Diagnostics Market By Product Type (Laboratory Analyzers, Point-of-Care Testing Devices, Reagents & Consumables, Software & Services); By Test Type (Routine Coagulation Tests, D-Dimer Tests, Fibrinolysis Tests, Platelet Function Tests, Heparin & DOAC Monitoring Tests); By End User (Hospital Laboratories, Independent/Reference Laboratories, Point-of-Care Settings, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Hemostasis Diagnostics Market will witness a robust CAGR of 6.2% , valued at $4.3 billion in 2024, expected to appreciate and reach $6.2 billiRead More

Published Date: NOV-2025 | No Of Pages:185 | $ 4485

In Situ Hybridization Market By Product Type (Probes, Reagents, Instruments, Kits); By Application (Gene Expression Analysis, Chromosome Analysis, Diagnostic Testing, Drug Development); By End-User (Research Institutes, Diagnostic Laboratories, Biopharmaceutical Companies, Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global In Situ Hybridization ( ISH ) Market is poised to experience robust growth from USD 1.3 billion in 2024 to USD 2... Read More

Published Date: NOV-2025 | No Of Pages:170 | $ 4485

Preimplantation Genetic Testing Market By Test Type (PGT-A, PGT-M); By Application (Fertility Clinics, Hospitals, Genetic Testing Labs); By End-User (Patients, Healthcare Providers, Reproductive Health Specialists); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Preimplantation Genetic Testing Market is set to experience robust growth, valued at $1.5 billion in 2024 , and projected to reach $4.0 billion by... Read More

Published Date: NOV-2025 | No Of Pages:176 | $ 4485

ATP Assays Market By Product Type (Luminescence Assays, Colorimetric Assays, Fluorescence Assays); By Application (Drug Discovery And Development, Microbial Detection, Diagnostics, Environmental Testing, Food & Beverage Testing); By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Food & Beverage Industry, Environmental Testing Laboratories, Hospitals & Diagnostic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global ATP Assays Market will witness a robust CAGR of 6.8 % , valued at around $325 million in 2024 , and exp... Read More

Published Date: NOV-2025 | No Of Pages:196 | $ 4485

Blood Based Biomarkers Market By Biomarker Type (Proteomic, Genomic, cfDNA/RNA, Metabolomic, Exosomal); By Application (Oncology, Cardiology, Neurology, Infectious Diseases, Autoimmune Disorders); By End User (Hospitals & Clinics, Diagnostic Laboratories, Academic & Research, Biopharma & Biotech); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Blood Based Biomarkers Market will witness a robust CAGR of 13.2% , valued at $28.6 billion in 2024 , and projected to reach around $60.6 billion by 2030 ... Read More

Published Date: NOV-2025 | No Of Pages:168 | $ 4485

Hospital EMR Systems Market by Product Type (Cloud-based, On-premise); By Application (Patient Management, Clinical Documentation, Prescription Management, Reporting & Analytics); By End-User (Hospitals, Ambulatory Care Centers, Long-term Care Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hospital EMR Systems Market is poised for significant growth over the forecast period, with an estimated market size of USD 40 billion in 2024. This marke... Read More

Published Date: NOV-2025 | No Of Pages:177 | $ 4485

Psychiatric Digital Biomarkers Market By Technology Platform (Wearables, Mobile Applications, Ambient Sensors); By Psychiatric Condition (Depression, Bipolar Disorder, PTSD, Schizophrenia, Anxiety Disorders); By End-User (Healthcare Providers, Pharmaceutical Companies, Research Institutions, Insurance Providers, Patients); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Psychiatric Digital Biomarkers Market is projected to grow at a robust CAGR of 23.5% , with an estimated valuation of $612 million in 2024 , set to surpas... Read More

Published Date: NOV-2025 | No Of Pages:195 | $ 4485

Digital Health Monitoring Devices Market By Product Type (Wearable Monitors, Remote Patient Monitoring Devices, Multiparameter Devices, Implantable Monitors); By Application (Cardiovascular Monitoring, Diabetes Management, Sleep Tracking, Respiratory Monitoring, Others); By End User (Hospitals and Clinics, Home Healthcare, Fitness & Wellness Centers, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Digital Health Monitoring Devices Market will witness a robust CAGR of 9.5 % , valued at $ 31.0 billion in ... Read More

Published Date: NOV-2025 | No Of Pages:188 | $ 4485

Immunoprotein Diagnostic Testing Market By Product Type (Reagents & Kits, Analyzers/Instruments); By Test Type (Immunoglobulin Testing, C-Reactive Protein Testing, Complement System Protein Testing, Prealbumin Testing, Haptoglobin Testing, Others); By Application (Infectious Disease Testing, Oncology, Autoimmune Diseases, Endocrinology, Allergy Testing, Others); By End User (Hospitals & Clinics, Diagnostic Laboratories, Research Institutes, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Immunoprotein Diagnostic Testing Market will witness a robust CAGR of 6.8% , valued at around USD 13.8 billion in 2024, expected to appreciate and reach nearly USD... Read More

Published Date: NOV-2025 | No Of Pages:176 | $ 4485

Bloodstream Infection Testing Market By Technology (Conventional Blood Culture, Molecular Diagnostics, Mass Spectrometry, Point-of-Care Testing); By Application (Bacterial Detection, Fungal Detection, Mycobacterial Detection); By End User (Hospitals, Reference Laboratories, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bloodstream Infection Testing Market will witness a robust CAGR of 7.9% , valued at $4.8 billion in 2024 , expected to appreciate and reach $8.1 billion by 20... Read More

Published Date: NOV-2025 | No Of Pages:157 | $ 4485

Fecal Calprotectin Test Market By Product Type (ELISA-Based Assays, Rapid Point-of-Care Tests); By Sample Throughput (Low-to-Medium Throughput Systems, High-Throughput Systems); By End User (Hospitals and Clinics, Diagnostic Laboratories, Physician Offices and Point-of-Care Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Fecal Calprotectin Test Market will witness a robust CAGR of 9.1% , valued at approximately $252 million in 2024, expected to appreciate ... Read More

Published Date: NOV-2025 | No Of Pages:168 | $ 4485

Membrane Chromatography Market By Product Type (Capsules & Cartridges, Cassettes, Syringe Filters, Membrane Plates); By Technique (Ion Exchange, Affinity, Hydrophobic Interaction, Others); By Operation Mode (Single-use, Reusable); By End User (Pharmaceutical & Biotechnology Companies, CROs/CMOs, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Membrane Chromatography Market will witness a robust CAGR of 13.2% , valued at USD 340 million in 2024 , expected to appreciate and reach USD 710 million by 2030Read More

Published Date: NOV-2025 | No Of Pages:193 | $ 4485

Healthcare Gamification Market By Component (Software, Services); By Application (Fitness & Wellness Management, Chronic Disease Management, Medication Adherence, Rehabilitation, Mental Health & Behavioral Therapy); By End User (Healthcare Providers, Payers & Insurers, Corporate Wellness Programs, Patients & Consumers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Healthcare Gamification Market will witness a robust CAGR of 20.8% , valued at approximately $5.6 billion in 2024, expected to appreciate and reach around... Read More

Published Date: NOV-2025 | No Of Pages:159 | $ 4485

Medical Specimen Tracking System Market By Technology (Barcode, RFID, Cloud-Based); By Sample Type (Blood, Tissue, Swabs, Others); By End User (Hospitals & Clinics, Diagnostic Labs, CROs, Biobanks); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Medical Specimen Tracking System Market is set to expand at a compelling CAGR of 10.3% , reaching $1.9 billion by 2030 , up from an estimated $1.0... Read More

Published Date: NOV-2025 | No Of Pages:173 | $ 4485

Influenza Diagnostics Market By Product Type (Molecular Diagnostics, Antigen Detection Kits, Serological Tests); By Application (Hospitals, Clinics, Diagnostic Laboratories, Public Health Organizations, Research Institutions, Point-of-Care); By End User (Healthcare Providers, Public Health Organizations, Consumers, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Influenza Diagnostics Market is poised for robust growth, with a projected CAGR of 7.5% from 2024 to 2030 . In 2024 , the market is valued at USD ... Read More

Published Date: NOV-2025 | No Of Pages:196 | $ 4485

mHealth Apps Market By App Type (Fitness & Wellness Apps, Chronic Disease Management Apps, Mental Health & Behavioral Therapy Apps, Women’s Health Apps, Telemedicine & Consultation Apps, Medication Adherence & Reminder Apps); By Platform (iOS, Android, Others); By End User (Individuals/Consumers, Healthcare Providers, Payers/Insurance Companies, Employers and Corporate Wellness Programs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Mhealth Apps Market will witness a robust CAGR of 15.8% , valued at $78.4 billion in 2024, expected to appreciate and reach $188.... Read More

Published Date: NOV-2025 | No Of Pages:193 | $ 4485

Mycoplasma Testing Market By Product Type (Instruments, Kits & Reagents, Services); By Technology (PCR-Based, ELISA-Based, Culture-Based); By Application (Biopharmaceutical Production, Clinical Diagnostics, Academic Research); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Mycoplasma Testing Market will witness a steady CAGR of 10.4% , valued at USD 980 million in 2024 , and expected to appreciate significantly to reach around USD 1.... Read More

Published Date: NOV-2025 | No Of Pages:174 | $ 4485

Rat Model Market By Model Type (Sprague-Dawley Rats, Wistar Rats, Genetically Modified Rats); By Application (Pharmaceutical Research, Biotechnology, Academic Research, CROs); By Region (North America, Europe, Asia Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Rat Model Market will witness a robust CAGR of 5.6% , valued at $1.2 billion in 2024 , expected to appreciate and reach $1.9 bill... Read More

Published Date: OCT-2025 | No Of Pages:162 | $ 4485

Covid-19 Diagnostics Market By Test Type (Molecular Diagnostics [PCR, Isothermal Amplification], Antigen Testing, Serology/Antibody Testing, Other Tests); By Sample Type (Nasopharyngeal Swabs, Saliva, Nasal Swabs, Others); By Mode of Testing (Laboratory Testing, Point-of-Care Testing, At-Home/Self-Testing); By End User (Hospitals and Clinics, Diagnostic Laboratories, Academic and Research Institutes, Pharmacies and Retail Stores, Home Users); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Covid -19 Diagnostics Market will witness a robust CAGR of 6.8% , valued at approximately $33.5 billion in 2024, expected to appreciate a... Read More

Published Date: OCT-2025 | No Of Pages:180 | $ 4485

CIS Insulin Market By Product Type (Human Insulin, Insulin Analogs [Basal, Prandial, Premixed]); By Route of Administration (Subcutaneous, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The CIS Insulin Market will witness a robust CAGR of 6.43% , valued at USD 1.2 billion in 2024, expected to appreciate and reach USD 1.68 billion by... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Pediatric Cancer Biomarkers Market By Biomarker Type (Genetic Biomarkers, Proteomic Biomarkers, Epigenetic Biomarkers, Metabolic Biomarkers, Others); By Cancer Type (Leukemia, Brain and CNS Tumors, Neuroblastoma, Wilms Tumor, Lymphomas, Bone Tumors, Others); By Technology Platform (Next-Generation Sequencing, PCR and qPCR, Immunohistochemistry, Microarrays, Mass Spectrometry, Others); By End User (Hospitals and Pediatric Cancer Centers, Diagnostic Laboratories, Academic and Research Institutions, Biopharmaceutical Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Pediatric Cancer Biomarkers Market will witness a robust CAGR of 13.8% , valued at approximately $1.24 billion in 2024 ,... Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485

Narcolepsy Therapeutics Market By Product Type (CNS Stimulants, Sodium Oxybate-Based Therapies, Selective Histamine H3 Receptor Antagonists/Inverse Agonists, Orexin Receptor Agonists); By Type (Type 1 Narcolepsy, Type 2 Narcolepsy); By Route of Administration (Oral, Oral Liquid, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Narcolepsy Therapeutics Market will witness a robust CAGR of 8.4% , valued at $3.1 billion in 2024, expected to appreciate and reach $5.0 billion<... Read More

Published Date: OCT-2025 | No Of Pages:196 | $ 4485

Meningitis Diagnostic Testing Market By Test Type (PCR-Based Tests, Latex Agglutination Tests, Culture Tests, ELISA Tests, Others); By Pathogen Type (Bacterial, Viral, Fungal, Parasitic & Others); By End User (Hospitals & Clinics, Diagnostic Laboratories, Point-of-Care Settings, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Meningitis Diagnostic Testing Market will witness a robust CAGR of 8.7% , valued at $2.3 billion in 2024 , expected to appreciate and reach $3.8 b... Read More

Published Date: OCT-2025 | No Of Pages:178 | $ 4485

Proteinase K Market By Form (Liquid, Lyophilized); By Application (DNA and RNA Extraction, Protein Digestion, In Situ Hybridization, Forensic Analysis, Food and Environmental Testing, Other Research Applications); By End User (Biotechnology & Pharmaceutical Companies, Diagnostic Laboratories, Academic and Research Institutes, Forensic Laboratories, Contract Manufacturing Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Proteinase K Market will witness a robust CAGR of 5.9% , valued at $135.2 million in 2024, expected to appreciate and reach $191.... Read More

Published Date: OCT-2025 | No Of Pages:168 | $ 4485

Pyrogen Testing Market By Test Type (LAL Test, Rabbit Pyrogen Test, Monocyte Activation Test); By Product Type (Reagents and Kits, Instruments, Services); By End User (Pharmaceutical and Biotechnology Companies, Medical Device Companies, CROs & CMOs, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pyrogen Testing Market will witness a robust CAGR of 10.2%, valued at USD 2.24 billion in 2024, and is expected to appreciate and reach <... Read More

Published Date: OCT-2025 | No Of Pages:160 | $ 4485

Antimicrobial Resistance (AMR) Diagnostics Market Antimicrobial Resistance Diagnostics Market By Technology (Molecular Diagnostics, Immunoassays, Microbial Culture, NGS, Microfluidics); By Pathogen (Bacterial, Mycobacteria, Fungal, Parasitic, Viral); By End User (Hospitals, Research, Pharma, Public Health, Point-of-Care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antimicrobial Resistance (AMR) Diagnostics Market will witness a dynamic CAGR of 9.2% , valued at approximately USD 4.6 billion in 2024Read More

Published Date: OCT-2025 | No Of Pages:185 | $ 4485

Antibody Fragments Market By Product Type (Fab, scFv, F(ab’)2, Nanobodies, Others); By Application (Therapeutics, Diagnostics, Research); By End User (Pharmaceutical & Biotech Companies, Research Institutes, CROs, Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antibody Fragments Market will witness a robust CAGR of 12.2% , valued at USD 5.8 billion in 2024, expected to appreciate and reach USD 11.6 billion by 20... Read More

Published Date: OCT-2025 | No Of Pages:166 | $ 4485

Allergy Diagnostics Market By Test Type (In Vivo Tests, In Vitro Tests); By Allergen Type (Food, Inhaled, Drug, Insect Venom, Others); By End User (Hospitals, Diagnostic Labs, Research Institutes, Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Allergy Diagnostics Market will witness a robust CAGR of 9.2%, valued at $8.1 billion in 2024 , expected to appreciate and reac... Read More

Published Date: OCT-2025 | No Of Pages:153 | $ 4485

Gaucher Disease Drugs Market By Product Type (Enzyme Replacement Therapy [ERT], Substrate Reduction Therapy [SRT], Gene Therapy, Other Therapies); By Treatment Type (Pharmacological Treatments, Gene Therapy); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Online Pharmacies, Research Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Gaucher Disease Drugs Market will witness a robust CAGR of 8.82 % , valued at USD 2.9 billion in 2024 , and is expected to appreciate and r... Read More

Published Date: OCT-2025 | No Of Pages:184 | $ 4485

Pigmentation Disorder Treatment Market By Product Type (Topical Products, Oral Medications, Injectable Treatments, Laser and Light Therapy); By Treatment Method (Pharmacological Treatments, Cosmetic Procedures, Light-based Treatments); By End User (Clinics and Dermatology Centers, Aesthetic Clinics, Home Care); By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Pigmentation Disorder Treatment Market will see significant growth from 2024 to 2030, driven by increasing awareness of skin conditions, rising demand for cosmetic treatments, and advancements in medical therapie... Read More

Published Date: OCT-2025 | No Of Pages:161 | $ 4485

Meningococcal Vaccines Market By Vaccine Type (Polysaccharide, Conjugate, Recombinant Protein-Based); By Serogroup Coverage (Monovalent, Bivalent, Quadrivalent, Pentavalent); By Distribution Channel (Public Health Agencies, Hospital Pharmacies, Retail Clinics); By End User (Hospitals, Pediatric Clinics, Military, Travel Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Meningococcal Vaccines Market will witness a robust CAGR of 8.4% , valued at $4.7 billion in 2024 , and is expected to appreciate and reach around $7.6 billion by ... Read More

Published Date: OCT-2025 | No Of Pages:178 | $ 4485

Respiratory Syncytial Virus (RSV) Vaccine Market By Vaccine Type (Live Attenuated Vaccines, Subunit Vaccines, mRNA Vaccines, Vector-Based Vaccines, Others); By Target Population (Infants, Older Adults, Pregnant Women, High-Risk Adults, Others); By Route of Administration (Intramuscular, Intranasal, Subcutaneous, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Respiratory Syncytial Virus (RSV) Vaccine Market will witness a robust CAGR of 17.3% , valued at $2.4 billion in 2024 , and is expec... Read More

Published Date: OCT-2025 | No Of Pages:196 | $ 4485

Cancer Vaccines Market By Vaccine Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines); By Disease Indication (Cervical Cancer, Prostate Cancer, Others); By End-User (Hospitals and Clinics, Research Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cancer Vaccines Market is set to experience a robust growth trajectory from 2024 to 2030 , driven by increased research and development activities, advancements in biotech... Read More

Published Date: OCT-2025 | No Of Pages:165 | $ 4485

Multi-Cancer Early Detection Market By Technology Platform (DNA Methylation Analysis, Next-Generation Sequencing, PCR-Based Technologies, Proteomics & Multi-omics Approaches); By Cancer Type Scope (Pan-Cancer Detection, Selected High-Incidence Cancer Panels); By End User (Hospitals and Cancer Centers, Reference Laboratories, Diagnostic Specialty Clinics, Direct-to-Consumer Channels); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Multi-Cancer Early Detection (MCED) Market will witness a robust CAGR of 16.8% , valued at $2.3 billion in 2024, expecte... Read More

Published Date: OCT-2025 | No Of Pages:170 | $ 4485

Influenza Vaccine Market By Vaccine Type (Inactivated, Recombinant, Live Attenuated); By Age Group (Adults, Children, Elderly); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Region (North America, Europe, Asia Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Influenza Vaccine Market will witness a robust CAGR of 5.1% , valued at $6.3 billion in 2024 , and is expected to appreciate to $8.9 billion by 2030 , con... Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market By Therapeutic Approach (First-Line, Second-Line, Other Treatments); By Drug Type (Biologics, Oral Therapies, IVIG & Steroids); By Route of Administration (Injectables, Oral Medications); By Region (North America, Europe, Asia Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market is expected to experience steady growth, with an estimated market value of $1.3 billion in 2024 , projected t... Read More

Published Date: OCT-2025 | No Of Pages:180 | $ 4485

Mass Spectrometry Market By Technology (Triple Quadrupole, TOF-MS, Orbitrap, Ion Trap, FT-MS); By Application (Pharmaceutical, Clinical Diagnostics, Environmental Testing, Food Safety, Forensic); By End User (Pharma & Biotech, Clinical Labs, Academic Institutes, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Mass Spectrometry Market will witness a steady CAGR of 9.3 % , valued at approximately USD 8.5 billion in 2024 , and is ... Read More

Published Date: OCT-2025 | No Of Pages:176 | $ 4485

Mouth Ulcer Treatment Market By Product Type (Corticosteroids, Antihistamines, Analgesics & Anesthetics, Antimicrobial Mouthwashes & Rinses, Nutritional Supplements, Natural & Herbal Products); By Route of Administration (Topical, Oral Systemic); By Distribution Channel (Retail Pharmacies & Drug Stores, Hospital Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Mouth Ulcer Treatment Market will witness a robust CAGR of 5.6% , valued at approximately $1.8 billion in 2024 , expecte... Read More

Published Date: OCT-2025 | No Of Pages:199 | $ 4485

Personalized Medicine Biomarkers Market By Biomarker Type (Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Other Biomarkers); By Application (Oncology, Cardiology, Neurology, Other Applications); By Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Immunoassays, Mass Spectrometry, Other Technologies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Personalized Medicine Biomarkers Market will witness a robust CAGR of 13.2% , valued at approximately $31.5 billion in 2024 , expected to appreciate and r... Read More

Published Date: OCT-2025 | No Of Pages:174 | $ 4485

Carbapenem Market By Product Type (Meropenem, Imipenem-Cilastatin, Ertapenem, Doripenem, Others); By Indication (Respiratory Infections, UTIs, Intra-abdominal Infections, Sepsis, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Carbapenem Market will witness a robust CAGR of 5.8% , valued at USD 3.62 billion in 2024 , expected to appreciate and reach USD 5.07 billion by 2030 , co... Read More

Published Date: OCT-2025 | No Of Pages:152 | $ 4485

Genitourinary Drugs Market By Drug Class (Hormonal Therapies, Anti-Infectives, Oncology Drugs, BPH Therapies, Erectile Dysfunction Drugs, Overactive Bladder Treatments, Others); By Route of Administration (Oral, Parenteral, Topical/Transdermal, Intravesical); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Genitourinary Drugs Market will witness a robust CAGR of 6.8% , valued at $45.2 billion in 2024, expected to appreciate ... Read More

Published Date: OCT-2025 | No Of Pages:200 | $ 4485

Endocrine Testing Market By Test Type (Thyroid Function, Diabetes, Reproductive Hormones, Adrenal Function, Growth Hormones, Others); By Technology (Immunoassay, Tandem Mass Spectrometry, Point-of-Care Devices, Others); By End User (Hospitals & Clinics, Diagnostic Laboratories, Research Institutions, Homecare); By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Endocrine Testing Market will witness a robust CAGR of 7.2% , valued at approximately USD 10.8 billion in 2024 , expected to appreciate and reach nearly <... Read More

Published Date: OCT-2025 | No Of Pages:154 | $ 4485

Anti-emetic Drugs Market By Drug Type (Serotonin Antagonists, NK1 Antagonists, Dopamine Antagonists, Corticosteroids); By Route of Administration (Oral, Intravenous, Transdermal); By End-User (Hospitals, Clinics, Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Antiemetic Drugs Market will witness a robust CAGR of 5.2% , valued at $8.5 billion in 2024, expected to appreciate and reach $12.5 billionRead More

Published Date: OCT-2025 | No Of Pages:158 | $ 4485

Critical Limb Ischemia Treatment Market By Treatment Type (Endovascular Treatment, Surgical Treatment, Pharmacological Treatment); By End User (Hospitals & Cardiovascular Centers, Clinics & ASCs, Other End Users); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Critical Limb Ischemia (CLI) Treatment Market will experience significant growth over the forecast period from 2024 to 2030, driven by advancements in medical technologies, an increasing global prevalence of vasc... Read More

Published Date: OCT-2025 | No Of Pages:150 | $ 4485

Subcutaneous Immunoglobulin Market By Product Type (Standard SCIG, High-Concentration SCIG); By Indication (Primary Immunodeficiency Diseases, Secondary Immunodeficiencies, Neurological Disorders, Other Autoimmune Disorders); By End User (Homecare Settings, Hospitals & Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Subcutaneous Immunoglobulin (SCIG) Market will witness a robust CAGR of 8.9% , valued at approximately $6.4 billion in 2024Read More

Published Date: OCT-2025 | No Of Pages:177 | $ 4485

Shingles Vaccine Market By Vaccine Type (Recombinant Subunit, Live Attenuated); By Route of Administration (Intramuscular, Subcutaneous); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Public Health Agencies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Shingles Vaccine Market will witness a robust CAGR of 8.6% , valued at approximately $4.2 billion in 2024 , and is expected to appreciate and reach nearly $7.0 bil... Read More

Published Date: OCT-2025 | No Of Pages:154 | $ 4485

Helicobacter pylori Diagnostics Market By Test Type (Urea Breath Test, Stool Antigen Test, Serology Tests, Molecular Tests); By End User (Hospitals & Clinics, Diagnostic Laboratories, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Helicobacter Pylori Diagnostics Market will witness a robust CAGR of 6.6% , valued at $730.5 million in 2024 , expected to appreciate and... Read More

Published Date: OCT-2025 | No Of Pages:168 | $ 4485

Bacterial and Viral Specimen Collection Market By Product Type (Swabs, Blood Collection Devices, Urine Collection Kits, Sputum Collection Devices); By Application (Clinical Diagnostics, Research Laboratories, Blood Banks, Epidemiological Studies); By End User (Hospitals, Diagnostic Laboratories, Public Health Organizations, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Bacterial And Viral Specimen Collection Market is poised for significant expansion from 2024 to 2030 , driven by the increasing global focus on infectious diseas... Read More

Published Date: OCT-2025 | No Of Pages:179 | $ 4485

Comprehensive Metabolic Panel Testing Market By Product Type (Basic CMP, Expanded CMP); By Application (Chronic Disease Management, Preventive Healthcare, Post-Surgery Monitoring); By End User (Hospitals, Diagnostic Laboratories, Clinics, Homecare and Remote Testing); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Comprehensive Metabolic Panel Testing Market will witness a robust CAGR of 7.2% , valued at $5.8 billion in 2024, and is projected to reach $9.8 b... Read More

Published Date: OCT-2025 | No Of Pages:192 | $ 4485

Medical Cannabis Market By Product Type (Flowers, Oils & Tinctures, Capsules, Edibles, Topicals); By Application (Chronic Pain, Neurology, Oncology, Mental Health Disorders, Others); By Route of Administration (Inhalation, Oral, Topical); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Medical Cannabis Market will witness a robust CAGR of 16.9% , valued at USD 21.3 billion in 2024, expected to appreciate and reach USD 54.7 billio... Read More

Published Date: OCT-2025 | No Of Pages:160 | $ 4485

Biopharmaceutical Excipients Market By Product Type (Binders, Preservatives, Stabilizers, Emulsifiers, Solvents); By Application (Injectable Formulations, Oral Drug Formulations, Vaccines); By End User (Pharmaceutical Manufacturers, Contract Manufacturing Organizations [CMOs], Biopharmaceutical Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Biopharmaceutical Excipients Market will experience a solid growth trajectory from USD 7.8 billion in 2024 to USD 11.5 billion by 2030 , reflecting a robust CAGR o... Read More

Published Date: OCT-2025 | No Of Pages:191 | $ 4485

Cannabis Extract Market By Extract Type (Full Spectrum, Broad Spectrum, Isolates); By Application (Pharmaceuticals, Food & Beverages, Personal Care, Recreational Use); By End User (Medical Users, Adult-Use Consumers, Industrial Buyers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cannabis Extract Market will witness a robust CAGR of 18.6% , valued at $12.4 billion in 2024, expected to appreciate and reach $34.2 billionRead More

Published Date: OCT-2025 | No Of Pages:179 | $ 4485

Autism Spectrum Disorder Treatment Market By Treatment Type (Pharmacological, Behavioral Therapies, Assistive Technologies, Digital Therapeutics, Complementary & Alternative Treatments); By Age Group (Children, Adolescents, Adults); By Distribution Channel (Hospitals & Clinics, Specialty Centers, Online Platforms, Home-Based Care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Autism Spectrum Disorder (ASD) Treatment Market will witness a robust CAGR of 7.6% , valued at $3.42 billion in 2024Read More

Published Date: OCT-2025 | No Of Pages:186 | $ 4485

Minimal Residual Disease (MRD) Testing Market Minimal Residual Disease Testing Market By Technology (Next-Generation Sequencing, Flow Cytometry, Polymerase Chain Reaction); By Application (Leukemia, Multiple Myeloma, Lymphoma, Solid Tumors); By End User (Hospitals & Cancer Centers, Diagnostic Laboratories, Biopharma, Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Minimal Residual Disease (MRD) Testing Market will witness a robust CAGR of 14.8%, valued at $1.26 billion in 2024 , and is expected to a... Read More

Published Date: OCT-2025 | No Of Pages:200 | $ 4485

Retinal Vein Occlusion (RVO) Treatment Market By Drug Class (Anti-VEGF Agents, Corticosteroids, Combination Therapies); By Disease Type (Central Retinal Vein Occlusion, Branch Retinal Vein Occlusion); By Distribution Channel (Hospital Pharmacies, Retail & Specialty Pharmacies, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Retinal Vein Occlusion (RVO) Treatment Market will witness a robust CAGR of 6.8% , valued at $1... Read More

Published Date: OCT-2025 | No Of Pages:171 | $ 4485

Primary Biliary Cholangitis (PBC) Market By Drug Type (Ursodeoxycholic Acid, Obeticholic Acid, and Other Drugs); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Region (North America, Europe, Asia Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Primary Biliary Cholangitis (PBC) Market will witness a robust CAGR of 8.01 % , valued... Read More

Published Date: OCT-2025 | No Of Pages:174 | $ 4485

Alpha Glucosidase Inhibitors Market By Drug Type (Acarbose, Miglitol, Voglibose, Others); By Indication (Type 2 Diabetes Mellitus, Prediabetes, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Alpha Glucosidase Inhibitors Market will witness a robust CAGR of 8.1% , valued at $1.32 billion in 2024 , expected to appreciate and reach $2.11 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:154 | $ 4485

Nicotine Replacement Therapy Market By Product Type (Gum, Patch, Inhaler, Nasal Spray, Lozenges); By Route of Administration (Oral, Nasal, Transdermal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Nicotine Replacement Therapy (NRT) Market will witness a robust CAGR of 6.7%, valued at $3.86 billion in 2024 , expected to appreciate an... Read More

Published Date: OCT-2025 | No Of Pages:163 | $ 4485

Predictive Genetic Testing and Consumer Genomics Market By Product Type (Predictive Testing Kits, Consumer Genomic Services, Carrier and Pharmacogenomics Kits); By Application (Disease Risk Assessment, Ancestry & Traits, Pharmacogenetics, Reproductive Planning); By End User (Direct Consumers, Hospitals & Clinical Labs, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Predictive Genetic Testing And Consumer Genomics Market will witness a robust CAGR of 11.8%, valued at $9.4 billion in 2024 , and is proj... Read More

Published Date: OCT-2025 | No Of Pages:176 | $ 4485

Bronchodilators Market By Drug Class (Beta-2 Adrenergic Agonists, Anticholinergics, Theophylline, Combination Therapies); By Route of Administration (Inhalation, Oral, Injectable); By Indication (Asthma, Chronic Obstructive Pulmonary Disease, Others); By End User (Hospitals, Retail Pharmacies, Homecare Settings, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Bronchodilators Market will witness a robust CAGR of 6.7 % , valued at $17.9 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:151 | $ 4485

Sustained Release Excipients Market By Product Type (Polymers [Natural, Synthetic], Coatings [Functional, Osmotic], Minerals, Gums & Lipids); By Formulation Type (Oral Tablets, Capsules, Injectables, Implants); By Route of Administration (Oral, Parenteral, Transdermal, Others); By End User (Pharmaceutical Companies, CMOs, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Sustained Release Excipients Market will witness a robust CAGR of 7.1% , valued at $2.97 billion in 2024 , and is expected to appreciate and reach $4.79 billion by... Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

Relapsed and Refractory Multiple Myeloma Treatment Market Relapsed and Refractory Multiple Myeloma (RRMM) Treatment Market By Treatment Modality (Immunomodulatory Drugs, Proteasome Inhibitors, Monoclonal Antibodies, CAR-T Cell Therapy, Bispecific Antibodies); By Line of Therapy (Second-Line Therapy, Third-Line and Beyond); By Route of Administration (Oral, Intravenous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Relapsed And Refractory Multiple Myeloma Treatment Market will witness a robust CAGR of 7.4% , valued at $16.8 billion in 2024Read More

Published Date: OCT-2025 | No Of Pages:160 | $ 4485

Ovarian Cancer Drugs Market By Drug Type (Chemotherapy Drugs, Targeted Therapy Drugs, Immunotherapy Drugs); By Treatment Approach (First-Line Treatment, Second-Line Treatment, Adjuvant Therapy); By Region (North America, Europe, Asia Pacific, LAMEA); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Ovarian Cancer Drugs Market will witness a robust CAGR of 7.6% , valued at $5.3 billion in 2024 , and is projected to reach $9.2 ... Read More

Published Date: OCT-2025 | No Of Pages:167 | $ 4485

Predictive Biomarkers Market By Biomarker Type (Genomic, Proteomic, Metabolomic, Epigenetic, Cell-Based); By Application (Oncology, Autoimmune, Cardiovascular, Neurology, Infectious Diseases); By End User (Pharma & Biotech, Hospitals, Diagnostic Labs, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Predictive Biomarkers Market will witness a robust CAGR of 14.8% , valued at USD 9.8 billion in 2024 , and is expected to appreciate and reach USD 22.6 billion by ... Read More

Published Date: OCT-2025 | No Of Pages:177 | $ 4485

OTC Dry Eye Drops Market By Product Type (Artificial Tears, Lubricant Eye Drops, Gel Drops, Specialty Formulations); By Formulation (Preservative-Free, With Preservatives); By Distribution Channel (Retail Pharmacies & Drug Stores, Online Pharmacies & E-commerce, Supermarkets/Hypermarkets); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global OTC Dry Eye Drops Market will witness a robust CAGR of 6.8% , valued at USD 3.42 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:173 | $ 4485

Muscle Relaxant Drugs Market By Drug Class (Centrally Acting Skeletal Muscle Relaxants, Direct-Acting Muscle Relaxants); By Route of Administration (Oral, Injectable); By Application (Musculoskeletal Conditions, Neurological Disorders, Perioperative and ICU Care); By End User (Hospitals, Outpatient Clinics, Rehabilitation Centers, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Muscle Relaxant Drugs Market will witness a robust CAGR of 5.8% , valued at $2.34 billion in 2024, expected to appreciate and reach $3.29 billion by 2030,... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Blood Screening Market By Technology (Nucleic Acid Testing, Immunoassay); By Product & Service (Reagents & Kits, Instruments, Software & Services); By End User (Blood Banks, Hospitals & Clinics, Plasma Fractionation Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Blood Screening Market will witness a steady CAGR of 9.2 % , valued at approximately $ 5.3 billion in 2024 , and is proj... Read More

Published Date: OCT-2025 | No Of Pages:163 | $ 4485

Tuberculosis Therapeutics Market By Drug Class (First-Line Therapy, Second-Line Therapy); By Disease Type (Active TB, Latent TB); By Route of Administration (Oral, Injectable); By Distribution Channel (Public Programs, Hospital Pharmacies, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Tuberculosis Therapeutics Market will witness a steady CAGR of 6.1% , valued at $1.34 billion in 2024 , and is expected to reach $1.91 billion by 2030 , c... Read More

Published Date: OCT-2025 | No Of Pages:196 | $ 4485

Alpha Emitter Market By Isotope Type (Actinium-225, Radium-223, Astatine-211, Lead-212, Others); By Application (Prostate Cancer, Bone Metastases, Leukemia & Lymphoma, Neuroendocrine Tumors, Others); By End User (Hospitals & Oncology Clinics, Radiopharmacies, Academic Institutions, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Alpha Emitter Market will witness a strong CAGR of 13.7% , valued at $990 million in 2024 , and is projected to grow significantly to reach around $2.15 billion by... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Iron Deficiency Anemia Therapy Market By Therapy Type (Oral Iron Supplements, Intravenous Iron Therapy, Erythropoiesis-Stimulating Agents); By Route of Administration (Oral, Intravenous); By End User (Hospitals, Clinics, Homecare, Specialty Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Iron Deficiency Anemia Therapy Market will witness a robust CAGR of 8.1% , valued at USD 3.9 billion in 2024 , expected to appreciate and reach US... Read More

Published Date: OCT-2025 | No Of Pages:153 | $ 4485

Animal Model Market By Animal Type (Mice, Rats, Pigs, Non-Human Primates, Others); By Application (Toxicology Testing, Disease Research, Drug Discovery, Others); By End User (Pharmaceutical Companies, Biotechnology Firms, Academic and Research Institutions, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Animal Model Market is set to experience steady growth from USD 2.5 billion in 2024 , with a projected market size of USD 4.5 billion by 2030 , reflecting... Read More

Published Date: OCT-2025 | No Of Pages:157 | $ 4485

Herpes Simplex Virus Treatment Market by Treatment Type (Antiviral Drugs, Vaccines); By Type of Infection (HSV-1, HSV-2); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Herpes Simplex Virus ( HSV ) Treatment Market is poised for significant growth, expected to grow at a CAGR of 5.7% valued at USD 9.8 billionRead More

Published Date: OCT-2025 | No Of Pages:178 | $ 4485

High Performance Liquid Chromatography Market By Product Type (Instruments, Consumables, Accessories); By Application (Pharmaceutical and Biotech Drug Development, Clinical Diagnostics, Food & Beverage Testing, Environmental Analysis, Forensic Science); By End User (Pharma Companies, CROs, Academic Institutes, Testing Labs, Government Agencies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global High Performance Liquid Chromatography ( HPLC ) Market will witness a steady CAGR of 6.4%, valued at approximately $6.2 billion in 2024Read More

Published Date: OCT-2025 | No Of Pages:195 | $ 4485

Cell Penetrating Peptide Market By Product Type (Short Peptides, Long Peptides, Hybrid Peptides); By Application (Drug Delivery, Gene Therapy, Cancer Therapy, Regenerative Medicine); By End-User (Pharmaceutical & Biotech Companies, Research Institutions, Healthcare Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Cell Penetrating Peptide (CPP) Market will experience substantial growth from USD 2.7 billion in 2024 to an estimated USD 10.24 billion by 2030 ... Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

Traumatic Brain Injury Biomarkers Market By Biomarker Type (Protein, Metabolomic, Genomic, MicroRNA, Others); By Application (Diagnostic, Prognostic, Drug Discovery & Clinical Trials, Monitoring & Therapeutics); By Sample Type (Blood, CSF, Saliva, Urine); By End User (Hospitals, Military, Research Institutes, Sports Organizations, Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Traumatic Brain Injury ( TBI ) Biomarkers Market will witness a robust CAGR of 9.4% , valued at USD 2.17 billion in 2024 , and is expecte... Read More

Published Date: OCT-2025 | No Of Pages:193 | $ 4485

Antimicrobial Resistance (AMR) Testing Market Antimicrobial Resistance Testing Market By Technology (Culture-based, Molecular, Whole Genome Sequencing, Automated Systems); By Pathogen Type (Gram-negative, Gram-positive, Mycobacterium, Fungi, Viruses); By End User (Hospitals, Public Health, Research, Independent Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antimicrobial Resistance ( AMR ) Testing Market will witness a steady CAGR of 5.3 % , valued at USD 6.5... Read More

Published Date: OCT-2025 | No Of Pages:198 | $ 4485

Roadside Drug Testing Devices Market By Product Type (Handheld Testing Devices, Bench-top Analyzers); By Drug Type Detected (Cannabis, Cocaine, Opioids, Amphetamines, Others); By End User (Law Enforcement Agencies, Highway Patrol Agencies, Forensic Laboratories, Workplace Testing Organizations); By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Roadside Drug Testing Devices Market will witness a robust CAGR of 8.1% , valued at USD 1.05 billion in 2024 , expected to appreciate and reach US... Read More

Published Date: OCT-2025 | No Of Pages:151 | $ 4485

Saliva Collection and Diagnostics Market By Product Type (Saliva Collection Devices, Saliva Diagnostic Kits & Assays); By Application (Infectious Disease Detection, Genetic and Genomic Testing, Cancer Biomarker Detection, Drug Abuse and Toxicology Testing, Hormone and Metabolic Testing); By End User (Diagnostic Laboratories, Hospitals and Clinics, Research Institutes and Academic Centers, Home Care and Direct-to-Consumer Testing); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Saliva Collection And Diagnostics Market will witness a robust CAGR of 9.2% , valued at approximately $ 4.1 billion in 2024Read More

Published Date: OCT-2025 | No Of Pages:190 | $ 4485

Substance Abuse Treatment Market By Treatment Type (Medication-Assisted Treatment, Behavioral Therapies & Counseling, Residential/Inpatient Treatment, Outpatient Treatment Programs); By Substance Type (Alcohol Dependence, Opioid Dependence, Cannabis Use Disorder, Cocaine and Stimulant Addiction, Prescription Drug Abuse, Others); By End User (Hospitals, Specialty Rehabilitation Centers, Private Clinics and Individual Practitioners, Government & Community Organizations, Telehealth and Digital Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Substance Abuse Treatment Market will witness a robust CAGR of 6.8% , valued at $21.3 billion in 2024 , expected to appreciate and reach $31.7 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:170 | $ 4485

Erythropoietin Drugs Market By Drug Class (Epoetin Alfa, Darbepoetin Alfa, Epoetin Beta, Others); By Application (Chronic Kidney Disease, Cancer, HIV, Surgical Procedures, Others); By Route of Administration (Intravenous, Subcutaneous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Erythropoietin Drugs Market will witness a robust CAGR of 8.2% , valued at $ 11.9 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Non-Hodgkin Lymphoma (NHL) Therapeutics Market By Therapy Type (Chemotherapy, Immunotherapy, Targeted Therapy, Stem Cell Transplantation); By Indication (B-cell NHL, T-cell NHL); By End-User (Hospitals, Oncology Clinics, Research Centers, Outpatient Treatment Centers); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction and Strategic Context

The global Non-Hodgkin Lymphoma (NHL) Therapeutics Market is expected to experience robust growth, reaching a market value of $15.2 billion in 2024 and growing to $32.5 billion by 20... Read More

Published Date: OCT-2025 | No Of Pages:178 | $ 4485

Precision Diagnostics Market By Technology (Next-Generation Sequencing, Polymerase Chain Reaction, In Situ Hybridization, Microarrays, Digital PCR & Emerging Techniques); By Application (Oncology, Infectious Diseases, Reproductive Health, Rare Diseases, Neurology, Cardiology, Others); By End User (Hospitals & Clinical Laboratories, Reference Laboratories, Academic & Research Institutions, Biopharmaceutical Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction and Strategic Context

The Global Precision Diagnostics Market will witness a robust CAGR of 10.4%, valued at $98.6 billion in 2024, expected to appreciate and reach $177.4 billion by 2030... Read More

Published Date: OCT-2025 | No Of Pages:162 | $ 4485